Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 22,094 | 18,317 | -6,604 | -1,100 | -3,455 |
| Depreciation Amortization | 810 | 404 | 1,465 | 1,078 | 706 |
| Income taxes - deferred | 142 | 71 | 340 | 177 | 118 |
| Accounts receivable | -8,626 | 6,408 | -5,890 | -11,768 | -6,919 |
| Other Working Capital | -13,021 | 2,538 | -10,119 | -15,875 | -8,739 |
| Other Operating Activity | 10,226 | -5,713 | 8,815 | 13,465 | 7,998 |
| Operating Cash Flow | $11,625 | $22,025 | $-11,993 | $-14,023 | $-10,291 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,000 | 4,991 | 4,298 | N/A | N/A |
| PPE Investments | -1,354 | -761 | -1,638 | -1,235 | -737 |
| Purchase Of Investment | N/A | N/A | -5,000 | N/A | N/A |
| Other Investing Activity | -58 | -7 | -26 | -19 | -13 |
| Investing Cash Flow | $588 | $4,223 | $-2,366 | $-1,254 | $-750 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 150 | 150 | 9,326 | 9,180 | 9,180 |
| Financing Cash Flow | $150 | $150 | $9,326 | $9,180 | $9,180 |
| Exchange Rate Effect | 377 | -77 | -47 | -16 | -4 |
| Beginning Cash Position | 14,680 | 14,680 | 19,760 | 19,760 | 19,760 |
| End Cash Position | 27,420 | 41,001 | 14,680 | 13,647 | 17,895 |
| Net Cash Flow | $12,740 | $26,321 | $-5,080 | $-6,113 | $-1,865 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,625 | 22,025 | -11,993 | -14,023 | -10,291 |
| Capital Expenditure | -1,354 | -761 | -1,638 | -1,235 | -737 |
| Free Cash Flow | 10,271 | 21,264 | -13,631 | -15,258 | -11,028 |